1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- Amgen Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Carotid Artery Stenosis Therapeutics Market: About this market
The carotid artery stenosis therapeutics market analysis considers sales from antithrombotics, antihyperlipidemic, and antihypertensives products. Our analysis also considers the sales of carotid artery stenosis therapeutics in Asia, Europe, North America, and ROW. In 2018, the antithrombotics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the use of antithrombotics as the first-line treatment option for carotid artery stenosis will play a significant role in the antithrombotics segment to maintain its market position. Also, our global carotid artery stenosis therapeutics market report looks at factors such as the increasing risk factors for carotid artery stenosis, increasing geriatric population, and growing awareness about carotid artery stenosis. However, the availability of substitutes, delay in diagnosis, and stringent regulations may hamper the growth of the carotid artery stenosis therapeutics industry over the forecast period.
Global Carotid Artery Stenosis Therapeutics Market: Overview
Growing awareness about carotid artery stenosis
The growing awareness about carotid artery stenosis is important for its prevention, as delay in the diagnosis of this disease can be life-threatening. Several awareness campaigns are being conducted globally for carotid artery stenosis that includes hemorrhagic strokes, ischemic strokes, and transient ischemic attacks. The demand for carotid artery stenosis therapeutics is increasing with the growing awareness about stroke management and carotid artery stenosis through multiple educational programs initiated by government organizations. For instance, May is observed as the National Stroke Awareness Month by the Division for Heart Disease and Stroke Prevention (DHDSP). Similarly, the Stroke Awareness Foundation promotes awareness among communities and families about the devastating effects of strokes and carotid artery stenosis. Such awareness programs lead to the expansion of the global carotid artery stenosis therapeutics market at a CAGR of over 4% during the forecast period.
Increasing demand for curative therapies
The lack of approved drugs, coupled with a high prevalence of carotid artery stenosis has driven the need for effective curative therapies. Also, the consumption of off-label drugs cause side-effects which is further increasing the demand for new curative therapies. Most patients are opting for alternative options such as stents, angioplasty, and carotid endarterectomy for the treatment of carotid artery stenosis. These developments are expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global carotid artery stenosis therapeutics market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading carotid artery stenosis therapeutics manufacturers, that include Amgen Inc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., and Sanofi.
Also, the carotid artery stenosis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The carotid artery stenosis therapeutics market analysis considers sales from antithrombotics, antihyperlipidemic, and antihypertensives products. Our analysis also considers the sales of carotid artery stenosis therapeutics in Asia, Europe, North America, and ROW. In 2018, the antithrombotics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the use of antithrombotics as the first-line treatment option for carotid artery stenosis will play a significant role in the antithrombotics segment to maintain its market position. Also, our global carotid artery stenosis therapeutics market report looks at factors such as the increasing risk factors for carotid artery stenosis, increasing geriatric population, and growing awareness about carotid artery stenosis. However, the availability of substitutes, delay in diagnosis, and stringent regulations may hamper the growth of the carotid artery stenosis therapeutics industry over the forecast period.
Global Carotid Artery Stenosis Therapeutics Market: Overview
Growing awareness about carotid artery stenosis
The growing awareness about carotid artery stenosis is important for its prevention, as delay in the diagnosis of this disease can be life-threatening. Several awareness campaigns are being conducted globally for carotid artery stenosis that includes hemorrhagic strokes, ischemic strokes, and transient ischemic attacks. The demand for carotid artery stenosis therapeutics is increasing with the growing awareness about stroke management and carotid artery stenosis through multiple educational programs initiated by government organizations. For instance, May is observed as the National Stroke Awareness Month by the Division for Heart Disease and Stroke Prevention (DHDSP). Similarly, the Stroke Awareness Foundation promotes awareness among communities and families about the devastating effects of strokes and carotid artery stenosis. Such awareness programs lead to the expansion of the global carotid artery stenosis therapeutics market at a CAGR of over 4% during the forecast period.
Increasing demand for curative therapies
The lack of approved drugs, coupled with a high prevalence of carotid artery stenosis has driven the need for effective curative therapies. Also, the consumption of off-label drugs cause side-effects which is further increasing the demand for new curative therapies. Most patients are opting for alternative options such as stents, angioplasty, and carotid endarterectomy for the treatment of carotid artery stenosis. These developments are expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global carotid artery stenosis therapeutics market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading carotid artery stenosis therapeutics manufacturers, that include Amgen Inc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., and Sanofi.
Also, the carotid artery stenosis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Amgen Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORK
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Amgen Inc.
- AstraZeneca Plc
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
Note: Product cover images may vary from those shown
